Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Host DiseaseHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingEtoposideRecurrenceThiotepaSalvage TherapyVincristineGranulocytesCarmustineCytophagocytosisHematopoiesisDisease-Free SurvivalIfosfamideAmyloidosisBoronic AcidsPyrazinesSurvival RateThalidomideStem CellsRetrospective StudiesCytarabineDexamethasoneHodgkin DiseaseCord Blood Stem Cell TransplantationPrednisoneTransplantation ChimeraSurvival AnalysisDoxorubicinNeoplasmsTissue DonorsBone MarrowTime FactorsRecombinant ProteinsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsPlatelet CountPOEMS SyndromeHistocompatibilityHistocompatibility TestingFollow-Up StudiesCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteBone Marrow PurgingTransplantation, IsogeneicBone Marrow CellsVidarabinePlasma CellsLeukemiaBlood Cell CountNeutropeniaLymphomaImmunophenotypingLeukocyte CountBlood CellsProspective StudiesPrognosisFatal OutcomeCytomegalovirus InfectionsGraft vs Leukemia EffectReceptors, Granulocyte Colony-Stimulating FactorFeasibility StudiesMyeloma ProteinsMyelodysplastic SyndromesFlow CytometryAnemia, AplasticGranulocyte-Macrophage Colony-Stimulating FactorParaproteinemiasBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLiver TransplantationT-Lymphocytes